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The evidence is clear: vaccines do not cause autism spectrum disorder (ASD). This fact sheet provides 
a summary of studies that were conducted by CDC or with CDC’s involvement. 
 
Recommended Childhood Vaccines and Autism 
 
Thimerosal, Autism, and Other Neurodevelopmental Outcomes 
Study Title Summary and Citation 
Prenatal and Infant 
Exposure to 
Thimerosal From 
Vaccines and 
Immunoglobulins and 
Risk of Autism 
Exposure to thimerosal, a vaccine preservative, has been said to be associated with the increased 
risk of ASD.  This study compared children with ASD to those without, and looked at prenatal and 
infant exposure to thimerosal from vaccines. This study found no difference in exposure to 
thimerosal between children with and without ASD.   
 Price CS, Thompson WW, Goodson B, Weintraub ES, Croen LA, et al. Prenatal and Infant 
Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism. 
Pediatrics. Epub 2010 Sep 13. 
Autism and 
Thimerosal-
Containing Vaccines: 
Lack of Consistent 
Evidence for an 
Association 
 
In 1992, Denmark and Sweden stopped using thimerosal in vaccines. This study compared the rate 
of ASD in these countries before and after thimerosal was removed. In both countries, ASD rates 
increased between 1987 and 1999. If thimerosal exposure was related to ASD, one would expect 
that ASD rates would decrease after 1992 when children were no longer being exposed.  
 Stehr-Green P, Tull P, Stellfeld M, Mortenson PB, Simpson D. Autism and thimerosal-
containing vaccines: lack of consistent evidence for an association. Am J Prev Med. 2003 
Aug;25(2):101-6. 
 
  
Study Title Summary and Citation 
Increasing exposure 
to antibody-
stimulating proteins 
and polysaccharides 
in vaccines is not 
associated with risk 
of autism  
 
This study looked at the number of antigens (substances in vaccines that cause the body’s immune 
system to produce disease-fighting antibodies) from vaccines during the first two years of life. 
Researchers compared children with ASD to children without ASD. The results showed that the total 
amount of antigen from vaccines received was the same between children with and without ASD.  
 DeStefano F, Price CS, Weintraub ES. Increasing exposure to antibody-stimulating proteins 
and polysaccharides in vaccines is not associated with risk of autism. J Pediatr. 2013 
Aug;163(2):561-7. Epub 2013 Mar 30.  
 Study Title Summary and Citation 
Safety of Thimerosal-
Containing Vaccines: 
A Two-Phased Study 
of Computerized 
Health Maintenance 
Organization 
Databases  
 
CDC used the Vaccine Safety Datalink (VSD) to look for possible links between thimerosal-
containing vaccines and a variety of health problems. CDC and VSD researchers found statistically 
significant associations between thimerosal and language delays and tics.  However, the 
associations were weak and were not consistent between study populations. The study found no 
link between thimerosal and ASD.   
 Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, et al. Safety of thimerosal-
containing vaccines: a two-phased study of computerized health maintenance 
organization databases. Pediatrics. 2003 Nov;112(5):1039-48. 
Early Thimerosal 
Exposure and 
Neuropsychological 
Outcomes at 7 to 10 
Years  
 
This study measured neurodevelopmental disorders in children. The study found only a few 
statistically significant associations between exposure from thimerosal and neuropsychological 
functioning. Results of this study show no link between thimerosal-containing vaccines and 
neurodevelopmental disorders in children.   
 Thompson WW, Price C, Goodson B, Shay DK, Benson P, et al. Early Thimerosal Exposure 
and Neuropsychological Outcomes at 7 to 10 Years. N Engl J Med 2007; 357:1281-1292. 
Neuropsychological 
Performance 10 Years 
After Immunization in 
Infancy With 
Thimerosal-
Containing Vaccines 
CDC funded this follow-up study in Italy that compared neuropsychological outcomes of children 
who were randomly assigned to receive one of two forms of diphtheria-tetanus-acellular pertussis 
vaccine (DTaP) in the first year of life: one containing thimerosal and the other containing 2-
phenoxyethanol. Ten years after vaccination, the two groups were tested on 24 neuropsychological 
outcomes. This study adds to the body of scientific evidence that thimerosal in vaccines is not 
harmful to children.   
 Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D'Elia L, et al. Neuropsychological 
Performance 10 Years After Immunization in Infancy With Thimerosal-Containing 
Vaccines. Pediatrics 2009;123(2):475 -482. 
 
Measles, Mumps, and Rubella (MMR) Vaccine and Autism 
Study Title Summary and Citation 
A Population-Based 
Study of Measles, 
Mumps, and Rubella 
Vaccination and 
Autism 
 
CDC has an ongoing cooperative agreement with the Danish Medical Research Council which 
supports a collaborative research program with Danish researchers and provides opportunities for 
CDC to study causes of developmental disabilities through Denmark’s unique public health 
infrastructure.   
This study, which followed more than 500,000 children over 7 years, found no association between 
the MMR vaccine and ASD.   
 Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, et al. A Population-Based 
Study of Measles, Mumps, and Rubella Vaccination and Autism. N Engl J Med 2002; 
347:1477-1482. 
 Study Title Summary and Citation 
Age at First Measles-
Mumps-Rubella 
Vaccination in 
Children With Autism 
and School-Matched 
Control Subjects: A 
Population-Based 
Study in 
Metropolitan Atlanta 
CDC conducted this study using data collected through the Metropolitan Atlanta Developmental 
Disabilities Surveillance Program. This study looked at MMR vaccination and ASD by comparing 
children who had been diagnosed with ASD to those who had not. The study included children 
vaccinated by the age of 18 months, 24 months, and 36 months. The findings revealed that 
vaccination between 24 and 36 months was slightly more common among children with ASD, and 
that association was strongest among children 3-5 years of age. This finding was most likely a result 
of immunization requirements for preschool special education program attendance in children with 
ASD.  
 DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C.  Age at First 
Measles-Mumps-Rubella Vaccination in Children With Autism and School-Matched 
Control Subjects: A Population-Based Study in Metropolitan Atlanta. Pediatrics 
2004;113(2):259 -266. 
Lack of Association 
between Measles 
Virus Vaccine and 
Autism with 
Enteropathy: A Case-
Control Study 
 
CDC supported a study to investigate the association between MMR vaccine, gastrointestinal tract 
(GI) disorders, and ASD. Researchers studied MMR vaccine timing and evaluated bowel tissue 
samples from 25 children with ASD and GI disorders and 13 children with GI disturbances alone, 
looking for a difference in the presence of measles vaccine virus in the samples between children 
with and without ASD. The study’s results showed that MMR vaccine does not trigger or exacerbate 
GI disorders or ASD.   
 Hornig M, Briese T, Buie T, Bauman ML, Lauwers G,et al. Lack of Association between 
Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study. PLoS ONE 
2008; 3(9): e3140.  
Is There a ‘Regressive 
Phenotype’ of Autism 
Spectrum Disorder 
Associated with the 
Measles-Mumps-
Rubella Vaccine? A 
CPEA Study 
The National Institute of Child Health and Human Development (NICHD) and CDC collaborated to 
study regressive autism and measles-mumps-rubella (MMR) vaccination.  This study used data from 
children with regressive autism and children without autism. The results showed no evidence of a 
link between regression in ASD and MMR vaccination.   
 Richler J, Luyster R, Risi S, Hsu WL, Dawson G. Is there a 'regressive phenotype' of Autism 
Spectrum Disorder associated with the measles-mumps-rubella vaccine? A CPEA Study. J 
Autism Dev Disord. 2006 Apr;36(3):299-316. 
 
